H3 Biomedicine

The partnership marries Foundation's genomic knowledgebase with H3's drug discovery engine and computational biology platform.

NEW YORK (GenomeWeb News) – BGI and H3 Biomedicine today announced they will sequence and publish data from next-generation sequencing-based research on pre-clinical cancer models.

This article has been updated to clarify the tools being co-developed by H3 Biomedicine and Sage Bionetworks

NEW YORK (GenomeWeb News) – Cancer biotherapeutics developer H3 Biomedicine said today that it will partner with Sage Bionetworks to develop new software aimed at supporting its efforts to predict human responses to certain drugs.

NEW YORK (GenomeWeb News) – Horizon Discovery and H3 Biomedicine today launched SyntheTx, a technology partnership created to provide novel oncology targets and early-stage drug discovery programs to drug manufacturers.

NEW YORK (GenomeWeb News) – Horizon Discovery and biopharmaceutical firm H3 Biomedicine today announced a collaboration to identify and validate a panel of novel cancer drug targets.

Compendia Bioscience said this week that H3 Biomedicine has signed a three-year licensing agreement to use Compendia's Oncomine tool suite, which includes Oncomine Concepts and Oncomine Power Tools.

"H3 Biomedicine is an independent entity that will have the scientific freedom to choose and follow targets it identifies using genomic insights and modern chemistry, coupled with a disciplined approach to drug discovery and development," an Eisai spokesperson told PGx Reporter.

H3 Biomedicine will use a pharmacogenomic approach to develop new oncology drugs.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.